By Steven Reinberg
HealthDay Reporter
THURSDAY, Feb. 2 (HealthDay News) — Be wary of buying the cholesterol-lowering drugs known as statins on the Internet, British researchers say.
Common statins such as Lipitor, Crestor or Zocor may not be the same as advertised and sites often don’t include warnings about side effects or even require a prescription, the researchers noted.
By Steven Reinberg
HealthDay Reporter
MONDAY, Jan. 30 (HealthDay News) — Cholesterol-lowering drugs known as statins are equally effective in men and women, a new study finds.
For both males and females, these drugs lowered the risk of a heart attack by about 20 percent, the researchers say. Previously, some thought that statins, which include Lipitor, Lovastatin and Crestor, benefited women less than men.
By Jenifer Goodwin
HealthDay Reporter
WEDNESDAY, Dec. 28 (HealthDay News) — Older adults with high levels of omega-3 fatty acids and vitamins B, C, D and E in their blood performed better on certain measures of thinking abilities, and also tended to have larger brain volume, a new study finds.
Seniors with high levels of trans fats in their blood fared worse on certain thinking tests than those with lower levels of the unhealthy fats, and also had more brain shrinkage.
THURSDAY, Dec. 1 (HealthDay News) — The first generic version of the cholesterol-lowering statin Lipitor (atorvastatin calcium) has been approved by the U.S. Food and Drug Administration.
Drug maker Ranbaxy Laboratories, based in India, has gained approval to produce the tablets in 10 milligram (mg), 20 mg, 40 mg and 80 mg strengths, the FDA said in a news release. The agency stressed that makers of generic drugs are required to pass the same production- and packaging-quality standards as producers of brand-name drugs.
THURSDAY, Nov. 17 (HealthDay News) — Inflammation caused by psoriasis may trigger changes in a person’s cholesterol, including weakening the function of high-density lipoprotein (HDL), the “good” cholesterol, new research suggests.
The researchers said that, if confirmed, their findings could help explain why people with psoriasis — a chronic skin condition — are at greater risk for heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe.
By Denise Mann
HealthDay Reporter
MONDAY, Nov. 14 (HealthDay News) — Preliminary research suggests that a single injection of a man-made protein might lower levels of “bad” cholesterol.
Given in the abdomen, AMG145 reduced low-density lipoprotein (LDL) cholesterol levels among a group of healthy volunteers. The shot turned off a newly identified cholesterol regulator, PCSK9, which interferes with the liver’s ability to clear bad cholesterol from the bloodstream.
FRIDAY, Nov. 11 (HealthDay News) — All U.S. children between the ages of 9 and 11 should be screened for high cholesterol, according to new guidelines endorsed by the nation’s leading group of pediatricians.
The recommendations are a major shift from current guidelines that suggest such testing be done only for children who have a family history of heart disease or high blood cholesterol, which is one of the major risk factors for heart disease.
WEDNESDAY, November 9, 2011 (Health.com) — Consuming less sodium has been shown to lower blood pressure, but for many people the health benefits this provides may be offset by a slight uptick in their cholesterol levels, a new analysis of previous research suggests.
The analysis, which was conducted by Danish researchers and published this week in the American Journal of Hypertension, found that sharply reducing sodium intake increases a person’s total cholesterol by about 2.5%, on average—potentially upping the risk of heart disease and heart attacks, the researchers say. Read More
WEDNESDAY, Oct. 5 (HealthDay News) — Three hours of vigorous exercise a week can reduce a man’s heart attack risk by 22 percent, a new study suggests.
The Harvard School of Public Health researchers also found that about 38 percent of that decreased risk was due to the beneficial effects of exercise on a man’s levels of “good” high-density lipoprotein (HDL) cholesterol.
TUESDAY, Sept. 13 (HealthDay News) — A treatment currently being studied may prevent progression of atherosclerosis, a condition caused by the build-up of plaque in artery walls that can lead to heart attack, according to new research.
In conducting the study, published in the Sept. 12 issue of The Lancet, researchers followed 130 patients with atherosclerosis who were randomly assigned to be treated with either the experimental heart drug dalcetrapib, or an inactive placebo over the course of two years. In the double-blind study, neither the researchers nor the patients knew who was taking the heart drug and who was taking the placebo.
| Text Size: |  |
|
